T1	Participants 129 185	children being treated for acute lymphoblastic leukaemia
T2	Participants 374 484	Children were investigated who were receiving glucocorticoid treatment for acute lymphoblastic leukaemia (ALL)
T3	Participants 862 870	children
T4	Participants 1006 1092	Nineteen children (8 male, 11 female) with a median age 5.9 years (range 2.6-13 years)
